575 related articles for article (PubMed ID: 16298038)
41. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
42. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
Mori H; Yamada Y; Kuno T; Hirose Y
Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
[TBL] [Abstract][Full Text] [Related]
43. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
[TBL] [Abstract][Full Text] [Related]
44. Density-dependent location and interactions of truncated APC and beta-catenin.
Davies ML; Roberts GT; Spiller DG; Wakeman JA
Oncogene; 2004 Feb; 23(7):1412-9. PubMed ID: 14647421
[TBL] [Abstract][Full Text] [Related]
45. The Wnt connection to tumorigenesis.
Behrens J; Lustig B
Int J Dev Biol; 2004; 48(5-6):477-87. PubMed ID: 15349822
[TBL] [Abstract][Full Text] [Related]
46. Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis.
Menéndez M; González S; Obrador-Hevia A; Domínguez A; Pujol MJ; Valls J; Canela N; Blanco I; Torres A; Pineda-Lucena A; Moreno V; Bachs O; Capellá G
Gastroenterology; 2008 Jan; 134(1):56-64. PubMed ID: 18166348
[TBL] [Abstract][Full Text] [Related]
47. Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene.
Prall F; Weirich V; Ostwald C
Histopathology; 2007 Feb; 50(3):318-30. PubMed ID: 17257127
[TBL] [Abstract][Full Text] [Related]
48. Colorectal cancer and genetic alterations in the Wnt pathway.
Segditsas S; Tomlinson I
Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
[TBL] [Abstract][Full Text] [Related]
49. Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.
Kurzik-Dumke U; Hörner M; Czaja J; Nicotra MR; Simiantonaki N; Koslowski M; Natali PG
Int J Mol Med; 2008 Jan; 21(1):19-31. PubMed ID: 18097612
[TBL] [Abstract][Full Text] [Related]
50. The subcellular destinations of APC proteins.
Bienz M
Nat Rev Mol Cell Biol; 2002 May; 3(5):328-38. PubMed ID: 11988767
[TBL] [Abstract][Full Text] [Related]
51. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
[TBL] [Abstract][Full Text] [Related]
52. Beta-catenin can bind directly to CRM1 independently of adenomatous polyposis coli, which affects its nuclear localization and LEF-1/beta-catenin-dependent gene expression.
Ki H; Oh M; Chung SW; Kim K
Cell Biol Int; 2008 Apr; 32(4):394-400. PubMed ID: 18262809
[TBL] [Abstract][Full Text] [Related]
53. The APC gene product and colorectal carcinogenesis.
Bonneton C; Larue L; Thiéry JP
C R Acad Sci III; 1996 Oct; 319(10):861-9. PubMed ID: 8977766
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers.
Wang X; Lam EK; Zhang J; Jin H; Sung JJ
Biochem Biophys Res Commun; 2009 Sep; 387(2):376-80. PubMed ID: 19607815
[TBL] [Abstract][Full Text] [Related]
55. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
56. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
[TBL] [Abstract][Full Text] [Related]
57. Recruitment of adenomatous polyposis coli and beta-catenin to axin-puncta.
Faux MC; Coates JL; Catimel B; Cody S; Clayton AH; Layton MJ; Burgess AW
Oncogene; 2008 Oct; 27(44):5808-20. PubMed ID: 18591934
[TBL] [Abstract][Full Text] [Related]
58. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
D'Orazio D; Muller PY; Heinimann K; Albrecht C; Bendik I; Herzog U; Tondelli P; Bauerfeind P; Müller H; Dobbie Z
Anticancer Res; 2002; 22(6A):3409-14. PubMed ID: 12530096
[TBL] [Abstract][Full Text] [Related]
60. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
